135 related articles for article (PubMed ID: 35098437)
1. A novel long non-coding RNA regulates the integrin, ITGA2 in breast cancer.
Verhoeff TJ; Holloway AF; Dickinson JL
Breast Cancer Res Treat; 2022 Feb; 192(1):89-100. PubMed ID: 35098437
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.
Chin SP; Marthick JR; West AC; Short AK; Chuckowree J; Polanowski AM; Thomson RJ; Holloway AF; Dickinson JL
Prostate; 2015 May; 75(7):723-34. PubMed ID: 25662931
[TBL] [Abstract][Full Text] [Related]
3.
Adorno-Cruz V; Hoffmann AD; Liu X; Dashzeveg NK; Taftaf R; Wray B; Keri RA; Liu H
Genes Dis; 2021 Jul; 8(4):493-508. PubMed ID: 34179312
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of UCA1 and ITGA2 in pancreatic cancer cells target the expression of miR-107 through focal adhesion pathway.
Gong J; Lu X; Xu J; Xiong W; Zhang H; Yu X
J Cell Physiol; 2019 Aug; 234(8):12884-12896. PubMed ID: 30569514
[TBL] [Abstract][Full Text] [Related]
5. Methylation-independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia.
Lian XY; Zhang W; Wu DH; Ma JC; Zhou JD; Zhang ZH; Wen XM; Xu ZJ; Lin J; Qian J
J Cell Physiol; 2018 Dec; 233(12):9584-9593. PubMed ID: 30132837
[TBL] [Abstract][Full Text] [Related]
6. Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.
Wafai R; Williams ED; de Souza E; Simpson PT; McCart Reed AE; Kutasovic JR; Waltham M; Snell CE; Blick T; Thompson EW; Hugo HJ
Breast Cancer Res; 2020 Dec; 22(1):136. PubMed ID: 33276802
[TBL] [Abstract][Full Text] [Related]
7. ITGA2 induces STING expression in pancreatic cancer by inducing DNMT1 degradation.
Meng J; Cai H; Sun Y; Wen S; Wu H; Ren D
Cell Oncol (Dordr); 2022 Dec; 45(6):1421-1434. PubMed ID: 36331797
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of ITGA2 by MiR-373 promotes cell migration in breast cancer.
Ding W; Fan XL; Xu X; Huang JZ; Xu SH; Geng Q; Li R; Chen D; Yan GR
PLoS One; 2015; 10(8):e0135128. PubMed ID: 26258411
[TBL] [Abstract][Full Text] [Related]
9. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
Langsenlehner U; Renner W; Yazdani-Biuki B; Eder T; Wascher TC; Paulweber B; Clar H; Hofmann G; Samonigg H; Krippl P
Breast Cancer Res Treat; 2006 May; 97(1):67-72. PubMed ID: 16317580
[TBL] [Abstract][Full Text] [Related]
10. Dampened Regulatory Circuitry of TEAD1/ITGA1/ITGA2 Promotes TGFβ1 Signaling to Orchestrate Prostate Cancer Progression.
Cruz SP; Zhang Q; Devarajan R; Paia C; Luo B; Zhang K; Koivusalo S; Qin L; Xia J; Ahtikoski A; Vaarala M; Wenta T; Wei GH; Manninen A
Adv Sci (Weinh); 2024 Mar; 11(11):e2305547. PubMed ID: 38169150
[TBL] [Abstract][Full Text] [Related]
11. Hypomethylation-mediated overexpression of ITGA2 stimulates cell invasion and migration of thyroid carcinoma.
Chen H; Zhang C; Li Y; Chen C
Histol Histopathol; 2023 Jul; 38(7):787-796. PubMed ID: 36420922
[TBL] [Abstract][Full Text] [Related]
12. Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway.
Ren D; Zhao J; Sun Y; Li D; Meng Z; Wang B; Fan P; Liu Z; Jin X; Wu H
J Exp Clin Cancer Res; 2019 Dec; 38(1):485. PubMed ID: 31818309
[TBL] [Abstract][Full Text] [Related]
13. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.
Heilmann K; Toth R; Bossmann C; Klimo K; Plass C; Gerhauser C
Oncogene; 2017 Nov; 36(46):6446-6461. PubMed ID: 28759043
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-128 inhibits EMT of human osteosarcoma cells by directly targeting integrin α2.
Liu X; Liang Z; Gao K; Li H; Zhao G; Wang S; Fang J
Tumour Biol; 2016 Jun; 37(6):7951-7. PubMed ID: 26700675
[TBL] [Abstract][Full Text] [Related]
16. Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast cancers.
Kang L; Sun J; Wen X; Cui J; Wang G; Hoffman AR; Hu JF; Li W
Eur J Cancer; 2015 Jan; 51(2):260-70. PubMed ID: 25465188
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA p10247, high expressed in breast cancer (lncRNA-BCHE), is correlated with metastasis.
Yang YX; Wei L; Zhang YJ; Hayano T; Piñeiro Pereda MDP; Nakaoka H; Li Q; Barragán Mallofret I; Lu YZ; Tamagnone L; Inoue I; Li X; Luo JY; Zheng K; You H
Clin Exp Metastasis; 2018 Mar; 35(3):109-121. PubMed ID: 29948648
[TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA
Calanca N; Paschoal AP; Munhoz ÉP; Galindo LT; Barbosa BM; Caldeira JRF; Oliveira RA; Cavalli LR; Rogatto SR; Rainho CA
Epigenetics; 2019 Aug; 14(8):741-750. PubMed ID: 31062660
[TBL] [Abstract][Full Text] [Related]
19. Is Integrin Subunit Alpha 2 Expression a Prognostic Factor for Liver Carcinoma? A Validation Experiment Based on Bioinformatics Analysis.
Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Luo Y; Zhu Y
Pathol Oncol Res; 2019 Oct; 25(4):1545-1552. PubMed ID: 30515639
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma.
Li X; Wu Z; Mei Q; Li X; Guo M; Fu X; Han W
Br J Cancer; 2013 Oct; 109(8):2266-78. PubMed ID: 24022190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
